Pain Management Options for Patients Taking Eliquis (Apixaban)

First-Line Options for Mild to Moderate Pain

Acetaminophen is recommended as the first-line treatment for mild to moderate pain in patients on anticoagulants, with a maximum dose of 4g daily, according to the British Journal of Cancer and Annals of Oncology guidelines 2, 3
The American College of Physicians recommends using acetaminophen with caution in patients with liver failure, and dosage should be reduced in those with hepatic insufficiency or history of alcohol abuse, as stated in the MMWR Recommendations and Reports 4
Topical analgesics such as lidocaine patches can be used safely for localized peripheral pain without systemic anticoagulant interaction, as suggested by the Mayo Clinic Proceedings 5

The National Comprehensive Cancer Network recommends that NSAIDs should generally be avoided in patients taking Eliquis due to increased bleeding risk, especially gastrointestinal bleeding 6, 7
If NSAIDs must be used for inflammatory pain, they should be used with extreme caution and for the shortest duration possible, according to the Annals of Oncology guidelines 1, 2
Patients at high risk for NSAID-related complications while on Eliquis include those over 60 years of age, with history of peptic ulcer disease, compromised fluid status, or renal dysfunction, as stated in the Journal of the National Comprehensive Cancer Network : JNCCN 6

The British Journal of Cancer and Annals of Oncology guidelines recommend that for moderate pain uncontrolled by acetaminophen, weak opioids such as codeine or tramadol can be used, either alone or in combination with acetaminophen 1, 3
For severe pain, strong opioids like morphine, oxycodone, or hydromorphone can be used with appropriate dosing and monitoring, as suggested by the Annals of Oncology 1, 2
Opioid analgesics are a safe and effective alternative to NSAIDs for patients on anticoagulants, according to the Journal of the National Comprehensive Cancer Network : JNCCN 6

The Journal of the National Comprehensive Cancer Network : JNCCN and Mayo Clinic Proceedings recommend that for neuropathic pain, consider anticonvulsants or antidepressants, which do not increase bleeding risk and can be safely used with Eliquis 5, 7
Tricyclic antidepressants should be used with caution in patients with cardiac disease, starting with low doses at bedtime, as stated in the Mayo Clinic Proceedings 5

The Anaesthesia and Journal of the National Comprehensive Cancer Network : JNCCN guidelines recommend that interventional pain procedures require temporary discontinuation of Eliquis, with specific discontinuation times based on renal function 8, 9
For high hemorrhagic risk procedures, Eliquis should be discontinued 3 days before the procedure when creatinine clearance is >30 mL/min, as suggested by the Anaesthesia 8

The Journal of the National Comprehensive Cancer Network : JNCCN recommends providing clear written instructions about medication schedules, potential side effects, and when to seek medical attention 6
Regular reassessment of pain control and medication side effects is essential, according to the Mayo Clinic Proceedings 5